Drug Discovery Informatics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Drug Discovery Informatics Market, By Workflow

7.1.  Drug Discovery Informatics Market, By Workflow Type, 2020-2027

7.1.1.    Discovery Informatics

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Development Informatics

7.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Drug Discovery Informatics Market, By Mode

8.1.  Drug Discovery Informatics Market, By Mode, 2020-2027

8.1.1.    Outsourced

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    In-house

8.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Drug Discovery Informatics Market, By Services  

9.1.  Drug Discovery Informatics Market, By Services Type, 2020-2027

9.1.1.    Sequence Analysis Platforms

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Molecular Modeling

9.1.2.1.        Market Revenue and Forecast (2016-2027)

9.1.3.    Docking

9.1.3.1.        Market Revenue and Forecast (2016-2027)

9.1.4.    Clinical Trial Data Management

9.1.4.1.        Market Revenue and Forecast (2016-2027)

9.1.5.    Other Services

9.1.5.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global Drug Discovery Informatics Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, By Workflow (2016-2027)

10.1.2.  Market Revenue and Forecast, By Mode (2016-2027)

10.1.3.  Market Revenue and Forecast, By Services Type (2016-2027)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.1.4.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.1.4.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.1.5.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.1.5.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, By Workflow (2016-2027)

10.2.2.  Market Revenue and Forecast, By Mode (2016-2027)

10.2.3.  Market Revenue and Forecast, By Services Type (2016-2027)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.2.4.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.2.4.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.2.5.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.2.5.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.2.6.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.2.6.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.2.7.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.2.7.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, By Workflow (2016-2027)

10.3.2.  Market Revenue and Forecast, By Mode (2016-2027)

10.3.3.  Market Revenue and Forecast, By Services Type (2016-2027)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.3.4.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.3.4.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.3.5.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.3.5.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.3.6.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.3.6.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.3.7.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.3.7.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, By Workflow (2016-2027)

10.4.2.  Market Revenue and Forecast, By Mode (2016-2027)

10.4.3.  Market Revenue and Forecast, By Services Type (2016-2027)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.4.4.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.4.4.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.4.5.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.4.5.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.4.6.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.4.6.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.4.7.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.4.7.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, By Workflow (2016-2027)

10.5.2.  Market Revenue and Forecast, By Mode (2016-2027)

10.5.3.  Market Revenue and Forecast, By Services Type (2016-2027)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.5.4.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.5.4.3.      Market Revenue and Forecast, By Services Type (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, By Workflow (2016-2027)

10.5.5.2.      Market Revenue and Forecast, By Mode (2016-2027)

10.5.5.3.      Market Revenue and Forecast, By Services Type (2016-2027)

Chapter 11.  Company Profiles

11.1.              Certara

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Boehringer Ingelheim International GmbH

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Infosys Ltd.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Charles River Laboratories

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Collaborative Drug Discovery, Inc.

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Eurofins DiscoverX Products

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Jubilant Biosys

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Selvita

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Novo Informatics Pvt. Ltd.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           ChemAxon Ltd.

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

11.11.           Albany Molecular Research Inc.

11.11.1.               Company Overview

11.11.2.               Product Offerings

11.11.3.               Financial Performance

11.11.4.               Recent Initiatives

11.12.           Oracle

11.12.1.               Company Overview

11.12.2.               Product Offerings

11.12.3.               Financial Performance

11.12.4.               Recent Initiatives

11.13.           Accenture

11.13.1.               Company Overview

11.13.2.               Product Offerings

11.13.3.               Financial Performance

11.14.           Agilent Technologies, Inc.

11.14.1.               Company Overview

11.14.2.               Product Offerings

11.14.3.               Financial Performance

11.15.           Illumina, Inc.

11.15.1.               Company Overview

11.15.2.               Product Offerings

11.15.3.               Financial Performance

11.15.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms